A phase I study of decitabine and rapamycin in relapsed/refractory AML
Year: 2013
Type: article
Study design: Clinical Trial
Source: Leukemia Research
Institutions: University of Rochester Medicine, University of Rochester
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Eisai
OpenAlex ID: W2164382526
